Alvotech’s Ustekinumab Passes Safety And Efficacy Milestone

Company Reports Fresh Data For AVT04 Biosimilar Rival To Stelara

 
• By Dave Wallace

Alvotech has announced success in its confirmatory clinical safety and efficacy study for its AVT04 ustekinumab candidate, a proposed biosimilar to Stelara.

Clinical Trial Icon
Alvotech has reported further clinical trial results for its ustekinumab candidate • Source: Shutterstock

More from Biosimilars

More from Products